Results 21 to 30 of about 55,987 (250)

Temporal trend of opioid and nonopioid pain medications: results from a national in-home survey, 2001 to 2018

PAIN Reports, 2022
. Introduction:. The opioid epidemic persists in the United States. The use of opioid medications is often assessed by claims data but potentially underestimated. Objectives:.
Yun Wang, Dan Wu, Alexandre Chan, Chih-Hung Chang, Vivian W.Y. Lee, Michael B. Nichol   +5 more
doaj   +1 more source

Subtypes in Patients Taking Prescribed Opioid Analgesics and Their Characteristics: A Latent Class Analysis

Frontiers in Psychiatry, 2022
BackgroundOwing to their pharmacological properties the use of opioid analgesics carries a risk of abuse and dependence, which are associated with a wide range of personal, social, and medical problems.
Christian Rauschert, Nicki-Nils Seitz, Sally Olderbak, Sally Olderbak, Oliver Pogarell, Tobias Dreischulte, Ludwig Kraus, Ludwig Kraus, Ludwig Kraus   +8 more
doaj   +1 more source

Central nervous system (CNS) medications and polypharmacy in later life: cross-sectional analysis of the English Longitudinal Study of Ageing (ELSA)

BMJ Open, 2020
Objectives Many central nervous system (CNS) medications are considered potentially inappropriate for prescribing in older people; however, these medications are common in polypharmacy (≥5 medicines) regimens.
Natasha Slater, Simon White, Martin Frisher   +2 more
doaj   +1 more source

Changes in analgesic strategies for lobectomy from 2009 to 2018Central MessagePerspective

JTCVS Open, 2021
Objective: To evaluate trends in the use of epidural analgesia and nonopioid and opioid analgesics for patients undergoing lobectomy from 2009 to 2018.
Theresa Lo, MD, Robin Schiller, MD, DMD, Karthik Raghunathan, MBBS, MPH, Vijay Krishnamoorthy, MD, MPH, PhD, Oliver K. Jawitz, MD, MHS, Srinivas Pyati, MBBS, MD, FCARCSI, Thomas Van De Ven, MD, PhD, Raquel R. Bartz, MD, Annemarie Thompson, MD, Tetsu Ohnuma, MD, MPH, PhD   +9 more
doaj   +1 more source

Recent Chemical and Pharmacological Developments on 14-Oxygenated-N-methylmorphinan-6-ones

Molecules, 2021
Adequate pain management, particularly chronic pain, remains a major challenge associated with modern-day medicine. Current pharmacotherapy offers unsatisfactory long-term solutions due to serious side effects related to the chronic administration of ...
Mariana Spetea, Helmut Schmidhammer
doaj   +1 more source

The Effect of Postoperative Pain Treatment on the Incidence of Anastomotic Insufficiency after Rectal and Rectosigmoideal Surgery

Prague Medical Report, 2013
The aim of prospective study was to evaluate the pain relief in the postoperative period and consumption of opioid and non-opioid analgesics as a risk factor of the anastomotic insufficiency after rectal and rectosigmoideal resection for carcinoma ...
S. Adámek, Olga Matoušková, O. Polanecký, S. Světlík, J. Skořepa, M. Šnajdauf   +5 more
doaj   +1 more source

Clinically important drug interactions with opioid and non-opioid analgesics [PDF]

Arhiv za farmaciju, 2018
Patients often seek advise from doctors and pharmacists about pain treatment. Opioid and non-opioid analgesics are the most commonly used drugs in the treatment of pain, but they have potential for pharmacodynamic and pharmacokinetic drug-drug ...
Vezmar-Kovačević Sandra, Vučićević Katarina, Vučenović-Topić Valentina, Rajkovača Zvezdana, Miljković Branislava   +4 more
doaj   +1 more source

Gamma‐aminobutyric acid transaminase genetic polymorphism is a candidate locus for responsiveness to opioid analgesics in patients with cancer pain: An exploratory study

Neuropsychopharmacology Reports, 2018
Aim Cancer pain impairs not only physical functions but also social functions and roles. Consequently, the overall health‐related quality of life of patients with cancer pain deteriorates. Opioid analgesics are recommended for treating moderate to strong
Yaeko Yokoshima, Masahiko Sumitani, Daisuke Nishizawa, Makoto Nagashima, Kazutaka Ikeda, Ryoji Kato, Jun Hozumi, Hiroaki Abe, Kenji Azuma, Rikuhei Tsuchida, Yoshitsugu Yamada, Japanese TR‐Cancer Pain Research Group   +11 more
doaj   +1 more source

Novel Synthetic Opioids (NSO) Use in Opioid Dependents Entering Detoxification Treatment

Frontiers in Psychiatry, 2022
IntroductionOver the last decade, the use of New/Novel Synthetic Opioids (NSO) has emerged as an increasing problem, and especially so in the USA. However, only little is known about the prevalence and history of NSO use in European heroin dependents ...
Michael Specka, Thomas Kuhlmann, Udo Bonnet, Jürgen Sawazki, Luzia Schaaf, Stefan Kühnhold, Renate Steinert, Torsten Grigoleit, Helmut Eich, Benita Zeiske, Antje Niedersteberg, Katharina Steiner, Fabrizio Schifano, Norbert Scherbaum   +13 more
doaj   +1 more source

The effect of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment on mortality risk among opioid-dependent people.

International Journal of Population Data Science, 2022
Background As dispensings for benzodiazepines and gabapentinoids have increased in recent years, risk of increased mortality has been identified, particularly when used with opioids. There is limited research examining use of these medicines among people
Chrianna Bharat, Natasa Gisev, Sebastiano Barbieri, Tim Dobbins, Sarah Larney, Michael Farrell, Louisa Degenhardt   +6 more
doaj   +1 more source